Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilenya
Gilenya
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
Fri, 07/13/18 - 11:52 am
patents
Novartis
MS
Gilenya
Celgene
exclusivity
FDA expands use of Novartis MS drug to pediatric patients
Yahoo/Reuters
Sat, 05/12/18 - 11:35 am
FDA
Novartis
Gilenya
pediatric
Biotechs Find Strength In Numbers In Treating Multiple Sclerosis
Investors Business Daily
Fri, 07/21/17 - 10:25 am
MS
multiple sclerosis
Roche
Celgene
Novartis
Biogen
ozanimod
Gilenya
Ocrevus
Extavia
Novartis' Gilenya patent loss sets MS market up for battle with early generics
Fierce Pharma
Thu, 04/13/17 - 06:49 pm
Novartis
Gilenya
MS
multiple sclerosis
generics
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Novartis
Biogen
Gilenya
Tecfidera
MS
multiple sclerosis
FDA updates label for Novartis' MS pill Gilenya after reports of brain infection
Fierce Pharma
Wed, 08/5/15 - 02:46 pm
FDA
Novartis
Gilenya
MS
multiple sclerosis
Will Biogen Win From Novartis MS Drug Safety Label Change?
Yahoo/24 7 Wall St
Tue, 08/4/15 - 06:54 pm
Biogen
Novartis
MS
multiple sclerosis
Gilenya
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Mon, 12/1/14 - 09:59 am
Novartis
Gilenya
MS
multiple sclerosis
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
Novartis reports positive data for Gilenya in key measures of MS disease activity
First Word Pharma
Fri, 09/12/14 - 10:22 am
Novartis
Gilenya
MS
multiple sclerosis
Novartis wants new treatment goal in MS
Pharmaphorum
Wed, 09/3/14 - 09:03 am
Novartis
MS
multiple sclerosis
Gilenya
IPO Stock Watch: Receptos Soars On MS Drug Results
Investors.com
Tue, 06/10/14 - 07:22 pm
IPOs
MS
multiple sclerosis
Receptos
RPC1063
Novartis
Gilenya
Novartis MS Drug Helps Traumatic Memories Fade in Mice
Bloomberg
Mon, 05/26/14 - 08:35 am
Novartis
PTSD
post traumatic stress disorder
Gilenya
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Gilenya
Novartis
MS
multiple sclerosis
Biogen Idec
Tecfidera
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Fri, 10/25/13 - 09:41 am
Novartis
Gilenya
Tecfidera
GSK
Seebri Breezhaler
COPD
Xolair
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Should Novartis Shareholders Be Worried About This?
Motley Fool
Sat, 08/31/13 - 10:37 am
Novarits
Gilenya
progressive multifocal leukoencephalopathy
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Fri, 08/30/13 - 09:32 am
Novartis
Gilenya
MS
multiple sclerosis
PML
FDA
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wed, 08/14/13 - 10:16 am
Receptos
Novartis
Gilenya
MS
multiple sclerosis
RPC1063
Pages
« first
‹ previous
1
2
3
4
next ›
last »